NOVADAQ Announces Participation in Upcoming Investor Conferences
08 Febrero 2017 - 3:05PM
NOVADAQ Technologies Inc. (NASDAQ:NVDQ) (TSX:NDQ), the leading
provider of proven comprehensive fluorescence imaging solutions
that improve clinical outcomes and reduce healthcare costs in
minimally invasive and open surgeries, today announced that it
plans to participate in two upcoming investor conferences.
Rick Mangat, President and Chief Executive
Officer, is scheduled to present at the RBC Capital Markets Global
Healthcare Conference in New York, NY on Wednesday, February 22 at
11:00am ET. A live and archived webcast of the presentation
will be available on the Company’s website at: www.novadaq.com
under the “Events” tab in the Investors section.
Management will also be participating in BTIG’s
Fourth Annual Medical Technology, Life Sciences, and Diagnostics
Conference in Snowbird, UT on March 2. Due to the 1x1 only format
of the event, no webcast is available.
About NOVADAQ Technologies
Inc. NOVADAQ’s global mission is to enable physicians
with point-of-care imaging solutions that provide real-time
clinically significant and actionable information to improve care
quality and lower healthcare costs. Using NOVADAQ’s SPY
fluorescence imaging technology, physicians can personalize therapy
and achieve optimal results through the precise visualization of
blood flow in vessels, micro-vessels, tissue perfusion and critical
anatomical structures during the course of treatment. SPY
technology enables the delivery of personalized therapies and the
achievement of the optimal results for each individual patient.
More than 225 peer-reviewed publications demonstrate that the use
of SPY technology will reduce post-procedure complication rates and
the cost of care for a broad variety of surgical treatments for
cancer, cardiovascular diseases and other conditions, helping to
ensure that patients benefit from the very best possible treatment
and outcome.
SPY Imaging Systems are U.S. Food and Drug
Administration 510(k) cleared, Health Canada licensed, CE Marked
and registered worldwide for use in multiple surgical specialties
and medical applications. The endoscopic version of SPY technology,
known as PINPOINT, combines the fluorescence imaging capabilities
of SPY with the high definition visible light visualization to
establish a new standard in the quality and performance of
minimally invasive surgery. NOVADAQ’s LUNA System is used to
visualize blood flow and tissue perfusion while treating patients
with atherosclerotic cardiovascular disease that impairs blood flow
to the extremities and increases the risk for the development of
complications such as acute and chronic non-healing wounds and limb
loss. NOVADAQ is the exclusive worldwide distributor of LifeNet
Health’s DermACELL acellular tissue products for wound and breast
reconstruction surgery.
NOVADAQ, SPY, PINPOINT, LUNA and the
illumination square design are registered trademarks of NOVADAQ
Technologies, Inc. DermACELL is a registered trademark of
LifeNet Health, Inc.
For more information, please contact:
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
investors@novadaq.com
Novadaq Technologies (NASDAQ:NVDQ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Novadaq Technologies (NASDAQ:NVDQ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024